Blossom, a UK-based company founded in 2018, is a leader in the Biotechnology and Health Care sectors, focusing on Medical Cannabis Products & Services. Through its expertise in pharmaceutical contract manufacturing, Blossom provides a comprehensive suite of services that extends to both the production and logistics of medical cannabis products.
The company's dedication to being a foremost expert in its field reflects its strategic approach to capturing a share of the rapidly expanding medical cannabis market. With a strong foothold in the United Kingdom, Blossom is well-positioned to leverage its strategic insights and logistical capabilities to scale its operations further.
Most recently, Blossom received a crucial boost from its Series A investment on 01 April 2022, highlighting investor confidence and supporting its growth ambitions. This financial infusion provides the necessary capital for Blossom to enhance its service offerings and expand its market reach.